Oakville, Ontario, September 20, 2007  —  Axiom Real-Time Metrics has won a coveted Companies-to-Watch Award, one of four separate awards categories that make up the 2007 Deloitte Technology Fast 50 Awards, which is celebrating its 10th anniversary as the pre-eminent technology awards program in Canada.

Companies-to-Watch Awards honour early-stage Canadian technology companies in business less than five years. These companies exemplify many of the winning characteristics of Deloitte Technology Fast 50 ranked companies, which are judged using a longer track record.

“Companies-to-Watch Award winners frequently go on to score high rankings in the Deloitte Fast 50 once they have a five-year track record,” said John Ruffolo, National Leader, Technology, Media & Telecommunications Industry Group, Deloitte. “Axiom Real-Time Metrics has quickly distinguished itself for its innovative technology and entrepreneurship, and this award recognizes its potential as a future leader in the Canadian technology industry.”

Axiom Real-Time Metric’s CEO, John L. Schroeter, credits his partner and chief application platform architect, President and CTO Andrew Schachter, and Schachter’s development and implementation team with the creation of an end-user-focused architecture that provides powerful yet people-friendly tools. “We have developed sophisticated tools to move clinical research from a laborious and slow paper-based process to a markedly more accurate, efficient and adaptive means,” says Schroeter. Axiom’s electronic data capture (EDC) tools create significant benefits for all stakeholders involved in the discovery, commercialization, clinical use and funding of pharmaceutical products and medical devices. Axiom’s Go³ Clinical Trial Workflow & Management Suite takes advantage of the real-time benefits of Software as a Service (SaaS) to facilitate clinical trial data capture and, in turn, provide clinical researchers with worldwide, instant access to real-time project metrics. This portal into key study-related information leads to the optimization of patient safety, resource allocation and issue management. It also means that much needed life-saving therapies and devices make it to market faster, while products that are unsafe and/or not efficacious are failed sooner.

Axiom’s Aware Real-Time Surveillance Tool, also offered as SaaS, is an electronic data capture, analysis and reporting solution used for patient registries and surveillance studies that track products and devices following regulatory approval and launch. Data capture using Axiom’s Aware Real-Time Surveillance affords a real-time picture of the rapidly evolving world of clinical medicine.  This proprietary database drives informed and timely decisions within pharmaceutical and device companies. Aware also enables physicians with a powerful tool to enhance clinical decisions, and it provides data to address the increasing demands of regulatory authorities, legislators, payors and patients to demonstrate the value and safety of new therapies in the real-world setting of clinical practice.

The majority of Companies-to-Watch winners are potential global leaders in technology sectors that didn’t even exist five years ago. To win the award, companies must display the kind of management expertise and superior technology that mark a successful early-stage company poised for continued growth. To qualify for the Companies-to-Watch Award, candidates must have been operating less than five years and have revenues less than $5 million. They must also be headquartered in Canada and devote a significant portion of their operating revenue to creating proprietary technology and/or intellectual property.

About the Deloitte Technology Fast 50 — This year marks the 10th anniversary of the Deloitte Technology Fast 50 program, which celebrates business growth, innovation and entrepreneurship.  The program features four distinct categories: the Deloitte Technology Fast 50 Ranking, Companies-to Watch Awards (honouring early-stage Canadian technology companies in business less than five years), Leadership Awards (Deloitte Technology Fast 50-ranked companies that demonstrate leadership in each of the four industry subcategories of emerging technologies, hardware, software and telecommunications) and the Deloitte Technology Green 15 Awards (honouring companies creating innovative and economically viable intellectual property in the burgeoning field of green technology). Deloitte Technology Fast 50 winners are automatically eligible for the prestigious Deloitte Technology Fast 500 ranking. Program sponsors include Deloitte, Gowlings, GrowthWorks, CIBC World Markets, Stonewood Group, Behr & Associates, and CATAAliance. For further information, visit www.fast50.ca or call 1-888-6fast50.

About Axiom Real-Time Metrics — Axiom delivers powerful yet intuitive electronic data capture, analysis and real-time reporting software for clinical trials and observational studies, partnered with focused strategic/scientific consulting. Axiom’s ASP model makes it easy for clients to access web-based clinical solutions all over the world. All projects are configured to client specifications, empowering them to focus on the research, not the technology required to conduct it. Axiom’s clinical research tools, which are audited and compliant with regulatory and industry standards, include Axiom Go³ Clinical Trial Workflow & Management Suite™, for clinical trials, and Axiom Aware Real-Time Surveillance™, for patient registries. Comprehensive integration of services and technology enables Axiom to configure superior, web-based, end-to-end solutions for optimized clinical research and real-time mapping of actual clinical practice.